Kura Oncology (KURA) Non-cash Items (2015 - 2026)

Kura Oncology (KURA) has 12 years of Non-cash Items data on file, last reported at $51.8 million in Q1 2026.

• Quarterly Non-cash Items rose 9.75% year-over-year to $51.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.8 million (up 9.75% YoY) and the FY2025 annual result came in at $36.6 million, up 374.89% from the prior year.
• Non-cash Items grew to $51.8 million in Q1 2026 per KURA's latest filing, from $36.6 million in the prior quarter.
• Across five years, Non-cash Items topped out at $57.5 million in Q1 2022 and bottomed at $4.4 million in Q4 2022.
• The 5-year median for Non-cash Items is $47.2 million (2024), against an average of $40.0 million.
• The widest annual swing landed in 2023, when Non-cash Items decreased 14.66%; it then surged 374.89% in 2025.
• Tracing KURA's Non-cash Items over 5 years: stood at $4.4 million in 2022, then surged by 35.13% to $6.0 million in 2023, then advanced by 29.27% to $7.7 million in 2024, then surged by 374.89% to $36.6 million in 2025, then surged by 41.53% to $51.8 million in 2026.
• Per Business Quant, the three latest KURA Non-cash Items figures stand at $51.8 million (Q1 2026), $36.6 million (Q4 2025), and $41.0 million (Q3 2025).

Peer Comparison